ClinicalTrials.gov
public full text
Public Domain
EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients
Detection of mutation / specific polymorphism of the EVER/TMC6 and/or EVER/TMC8 gen.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC#1141079
- Mutational Profiling in Colorectal Tumors to Determine Its Role in the Diagnosis, Prognostic Significance and Their Impact in Clinical Management#1128229
- A machine learning framework for predictive interpretation of variants of uncertain significance in hereditary cancer.#469129
- Driver mutation impact in Chinese hepatocellular carcinoma#483566
- Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors#1088486
Record · ID 1096723
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive